Key result
Chronic anticoagulation averts thromboembolic complications in a patient with a 6-year misplaced LV defibrillator lead.
Why the study?
Lead insertion into the left ventricle is rare but carries dangerous risks of thromboembolic events, making prompt diagnosis and intervention essential.
Case Report (n=1)
No
Highlights the rare but dangerous complication of inadvertent left ventricular lead placement and the protective role of anticoagulation against systemic thromboembolism.
Anticoagulation may avert thromboembolism after inadvertent LV lead placement; leaves open optimal management pending larger studies.
Device insertion is a common cardiovascular procedure. Devices are implanted into the right heart, acting as a safeguard against systemic thromboembolism. Lead insertion into the left ventricle is rare, but carries dangerous consequences of thromboembolic events. Diagnosis and intervention of an inadvertently placed lead is essential. This is a case of a defibrillator lead inadvertently inserted into the left cavity, discovered 6 years after implantation.
No takes yet. Share an insight, caveat, or question.
Osman et al. (2021) conducted a case report in Misplaced defibrillator lead in the left ventricular cavity (n=1). Chronic anticoagulation was evaluated on Thromboembolic complications. A 76-year-old man with an inadvertently placed defibrillator lead in the left ventricular cavity for 6 years avoided thromboembolic complications due to chronic anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: